Literature DB >> 30029895

Association between IL-15 and insulin plasmatic concentrations in patients with pulmonary tuberculosis and type 2 diabetes.

Roberto Sánchez-Jiménez1, Eduarda Cerón2, Demetrio Bernal-Alcántara2, Manuel Castillejos-López3, Eva Gonzalez-Trujano4, Maria Cristina Negrete-García2, Noé Alvarado-Vásquez5.   

Abstract

IL-15 is part of the immune response in pulmonary tuberculosis (PTB) but amazingly, it may also induce physiological effects similar to those of insulin. We evaluated the IL-15 and insulin plasmatic levels in adults with PTB and with or without type 2 diabetes mellitus (DM2), who received previous antituberculosis therapy for at least 2 months. We analyzed the concentrations of glucose, glycated hemoglobin, insulin, as well as levels of IL-15, IL-2, IFN-γ, and TNF-α in patients with PTB, patients with PTB-DM2, household contacts with DM2 (C-DM2), and healthy household contacts (H-C). Our results showed unexpected high levels of glucose, insulin, and IL-15 in the PTB and C-DM2 groups. In comparison, low levels of these same indicators were observed in the PTB-DM2 and H-C groups. Interestingly, our analysis showed a positive correlation of IL-15 with insulin in the PTB group (r = 0.73) and in the C-DM2 group (r = 0.66). In comparison, a weak correlation between IL-15 and insulin was observed in the PTB-DM group (r = 0.10) and in the H-C group (ρ = 0.26). Our results suggest an association between IL-15 and insulin levels in the patient with PTB. Intriguingly, this association was weaker in the patient with PTB-DM2.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Insulin; Interleukin-15; Pulmonary tuberculosis; Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30029895     DOI: 10.1016/j.tube.2018.06.009

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  1 in total

1.  The association of glycemic level and prevalence of tuberculosis: a meta-analysis.

Authors:  Zhifei Chen; Qi Liu; Ranran Song; Wenxin Zhang; Tingping Wang; Zhan Lian; Xuezhi Sun; Yanli Liu
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.